KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Interest Expenses (2016 - 2025)

Evolent Health (EVH) has 10 years of Interest Expenses data on record, last reported at $19.0 million in Q4 2025.

  • For Q4 2025, Interest Expenses rose 182.89% year-over-year to $19.0 million; the TTM value through Dec 2025 reached $57.5 million, up 132.47%, while the annual FY2025 figure was $57.5 million, 132.47% up from the prior year.
  • Interest Expenses reached $19.0 million in Q4 2025 per EVH's latest filing, up from $16.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $19.0 million in Q4 2025 and bottomed at $2.1 million in Q2 2022.
  • Average Interest Expenses over 5 years is $9.0 million, with a median of $6.4 million recorded in 2022.
  • Peak YoY movement for Interest Expenses: crashed 65.76% in 2022, then soared 573.09% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $6.4 million in 2021, then rose by 0.97% to $6.4 million in 2022, then soared by 90.36% to $12.2 million in 2023, then tumbled by 45.09% to $6.7 million in 2024, then soared by 182.89% to $19.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $19.0 million in Q4 2025, $16.5 million in Q3 2025, and $11.6 million in Q2 2025.